Canada markets closed

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.1800+0.0300 (+2.61%)
At close: 04:00PM EDT
1.1600 -0.02 (-1.69%)
After hours: 06:09PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
7,588
7,588
6,416
3,082
2,495
Selling General and Administrative
5,714
5,714
7,136
2,505
393
Total Operating Expenses
13,302
13,302
13,552
5,587
2,888
Operating Income or Loss
-13,302
-13,302
-13,552
-5,587
-2,888
Interest Expense
11
11
15
0
0
Total Other Income/Expenses Net
2,394
2,394
1,143
2,700
61
Income Before Tax
-11,280
-11,280
-12,340
-4,041
-2,828
Income from Continuing Operations
-11,280
-11,280
-12,340
-4,041
-2,828
Net Income
-11,280
-11,280
-12,340
-4,041
-2,828
Net Income available to common shareholders
-11,280
-11,280
-12,340
-4,041
-2,828
Basic EPS
-0.94
-
-1.07
-0.65
-0.26
Diluted EPS
-0.94
-
-1.07
-0.65
-0.26
Basic Average Shares
12,307
-
11,505
6,243
10,944
Diluted Average Shares
12,307
-
11,505
6,243
10,944